Plexus (NASDAQ:PLXS) Issues Q2 2025 Earnings Guidance

Plexus (NASDAQ:PLXSGet Free Report) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.460-1.610 for the period, compared to the consensus EPS estimate of 1.610. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

Plexus Trading Down 10.1 %

Plexus stock opened at $153.30 on Friday. Plexus has a 12 month low of $90.18 and a 12 month high of $172.89. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. The business’s fifty day simple moving average is $162.30 and its two-hundred day simple moving average is $141.25. The company has a market capitalization of $4.15 billion, a price-to-earnings ratio of 35.57 and a beta of 0.91.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.43%. As a group, equities analysts predict that Plexus will post 6.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on PLXS shares. Benchmark restated a “buy” rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday. Stifel Nicolaus raised their price target on Plexus from $136.00 to $150.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. KeyCorp started coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating for the company. StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, Needham & Company LLC upped their price target on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $162.33.

View Our Latest Stock Analysis on Plexus

Insider Activity at Plexus

In other news, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total transaction of $234,585.00. Following the completion of the sale, the chief executive officer now directly owns 74,271 shares of the company’s stock, valued at approximately $11,615,241.69. The trade was a 1.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $165.90, for a total transaction of $497,700.00. Following the completion of the sale, the insider now directly owns 5,605 shares of the company’s stock, valued at approximately $929,869.50. This trade represents a 34.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,091 shares of company stock valued at $5,377,960 over the last 90 days. 1.76% of the stock is owned by corporate insiders.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.